Tenure Track Investigator

The Women’s Malignancies Branch (WMB), Center for Cancer Research (CCR) of the National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, Maryland, invites applications for a clinical tenure track principal investigator position in breast and ovarian cancer research or other malignancies. The applicant must have an MD-or equivalent degree, be board certified in Medical Oncology, have a strong record of clinical research accomplishments, and the potential to establish a vigorous mechanism-based clinical research program investigating the treatment of breast and/or gynecological malignancies. The position provides salary and full funding for a clinical research program, including office space, budget, support staff, and clinical and translational research infrastructure. Salary will be commensurate with education and experience. The WMB (https://ccr.cancer.gov/Womens-Malignancies-Branch) is dedicated to improving the outcomes for patients with breast and gynecological malignancies. Specific areas of active research within WMB include: receptor tyrosine kinase signaling, induction of apoptosis in breast cancer cells, prevention of metastasis, the role of NFk-B in ovarian cancer, and targeting defects in the DNA damage response pathways in breast and ovarian cancer. Applicants with interest in therapies targeting DNA damage pathways or other key pathways in breast and ovarian cancer are encouraged to apply. The NIH is dedicated to building an inclusive and diverse community in its training and employment programs. Applicants should e-mail a CV and bibliography, statement of research interests (no more than two pages) to: Dr. Brigitte Widemann, Search Chair, c/o Steven Svoboda, svobodasb@mail.nih.gov. Finalists will be notified when references are required. The search will remain open until a qualified applicant is found. Review of applicants will begin on or about September 1, 2015. 

About NCI's Center for Cancer Research

The Center for Cancer Research (CCR) is the intramural research component of the National Cancer Institute (NCI). CCR’s enabling infrastructure facilitates clinical studies at the NIH Clinical Center, the world’s largest dedicated clinical research complex; provides extensive opportunities for collaboration; and allows scientists and clinicians to undertake high-risk, high-impact laboratory- and clinic-based investigations. Investigators are supported by a wide array of intellectual and technological and research resources, including animal facilities and dedicated, high quality technology cores in areas such as imaging/microscopy, chemistry/purification, mass spectrometry, flow cytometry, genomics/DNA sequencing, transgenics and knock out mice, arrays/molecular profiling, and human genetics/bioinformatics. For an overview of CCR, please visit: http://ccr.cancer.gov/